Persisting Decline in Depression Treatment After FDA Warnings

This study of depression treatment in the wake of FDA warnings regarding suicide in children taking antidepressants found that the frequency of depression diagnoses decreased and continues to decrease.  Substitute care did not compensate in non-adult groups and the authors conclude that the spillover effects of the FDA warnings were non-transitory, substantial, and diffuse in a large population.   

Libby, A. M., H. D. Orton, et al. (2009). Persisting decline in depression treatment after FDA warnings. Arch Gen Psychiatry. 66(6), 633-9. http://archpsyc.ama-assn.org/cgi/content/short/66/6/633

Authors: Anne M. Libby, Heather D. Orton, Robert J. Valuck.